Header cover image

Chinese Pharmaceuticals & Biotech Top Growth Stocks

Results

8

1 new
According to our Simply Wall St analysis these are the best growth companies.. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.

8 companies

Xiamen Amoytop Biotech

Market Cap: CN¥34.8b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

688278

CN¥85.15

7D

2.4%

1Y

22.8%

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥11.9b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

300181

CN¥17.18

7D

-0.3%

1Y

5.1%

Boji Medical TechnologyLtd

Market Cap: CN¥3.6b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

300404

CN¥9.38

7D

-3.2%

1Y

-4.8%

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥27.0b

A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.

688192

CN¥58.54

7D

-6.0%

1Y

29.2%

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.4b

Shanghai Rightongene Biotechnology Co., Ltd.

688217

CN¥25.30

7D

-7.4%

1Y

8.0%

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥14.8b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

603707

CN¥9.18

7D

-4.4%

1Y

-32.6%

AcrobiosystemsLtd

Market Cap: CN¥8.8b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.

New

301080

CN¥52.71

7D

-4.9%

1Y

61.7%

Pacific Shuanglin Bio-pharmacy

Market Cap: CN¥12.7b

Engages in research, development, production, and sales of blood products in China and internationally.

000403

CN¥13.38

7D

-7.2%

1Y

-17.4%